AZIENDA OSPEDALIERA PER L EMERGENZA CANNIZZARO

Their core work

Azienda Ospedaliera per l'Emergenza Cannizzaro is a public emergency hospital in Catania, Sicily, whose EU research participation reflects a deliberate push into digital pathology and AI-assisted diagnostics. Rather than conducting bench research, they contribute as a clinical partner — supplying real-world patient cases, pathology data, and hospital-based validation environments for advanced computational tools developed by academic and ICT partners. Their involvement in both a large-scale multimodal analytics project and Europe's central digital pathology repository shows they are actively building internal capacity to adopt AI-driven diagnostic workflows. In practice, they sit at the intersection of clinical medicine and health informatics, bridging research prototypes and real hospital use.

What they specialise in

How they've shifted over time

Their first H2020 project (EXA MODE, 2019) placed them deep in technical infrastructure work — multimodal data, ontologies, knowledge graphs, image segmentation and compression — reflecting a role in providing clinical data and use cases for a complex analytics platform. By 2021, with BIGPICTURE, the focus narrowed and became more clinical: artificial intelligence and digital pathology, with an emphasis on standardized data repositories rather than algorithmic foundations. The trajectory is a clear move from foundational data engineering toward clinical AI deployment and interoperability, which mirrors the broader digitization of hospital pathology departments across Europe.

Cannizzaro is moving from data infrastructure participation toward clinical AI adoption, making them a credible candidate for future projects in federated clinical data networks, AI regulation in medical devices (EU AI Act), or digital pathology interoperability standards.

How they like to work

Cannizzaro joins exclusively as a participant — they have not coordinated a single H2020 project — which is typical for a hospital whose primary mission is patient care, not research management. Both of their projects are large consortia (EXA MODE and BIGPICTURE each involve dozens of partners), so they are experienced at operating within complex multi-partner structures without taking the administrative lead. Their value to a consortium is clinical: real patient data, pathology workflows, and hospital-based validation — roles that require trust and regulatory compliance rather than project leadership.

Despite only two projects, Cannizzaro has touched 58 unique consortium partners across 16 countries — a wide footprint explained by the large consortium sizes of EXA MODE and BIGPICTURE rather than a long project history. Their network consists primarily of European academic medical centers, ICT research groups, and hospital systems, with no apparent geographic clustering outside of Italy.

What sets them apart

Cannizzaro is one of the few public emergency hospitals in southern Italy with active participation in frontier digital pathology and AI imaging research at the European level, which is unusual for a regional hospital outside the major research clusters of Milan or Rome. Their dual membership in EXA MODE and BIGPICTURE — two complementary projects covering the full pipeline from analytics methodology to clinical data infrastructure — gives them a coherent, end-to-end positioning in the digital pathology space. For consortium builders who need a clinical partner with real emergency and pathology workflows, regulatory experience as a public health authority, and an established track record in large EU projects, Cannizzaro offers a distinctive southern European anchor.

Highlights from their portfolio

• EXA MODE
  Largest funding project for this organization (EUR 157,500) and technically the most demanding — combining extreme-scale analytics, multimodal ontologies, and medical image segmentation in a single RIA consortium.
• BIGPICTURE
  One of Europe's flagship digital pathology infrastructure projects (2021-2027) building a continent-wide AI-ready slide repository; Cannizzaro's inclusion places them inside a defining initiative for the future of clinical pathology.